Predictors of Healthy Mood and Memory After Oophorectomy

Trial Profile

Predictors of Healthy Mood and Memory After Oophorectomy

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Estradiol (Primary) ; Lisdexamfetamine (Primary)
  • Indications Cognition disorders; Memory disorders; Mood disorders
  • Focus Pharmacodynamics
  • Acronyms E2-LDX
  • Most Recent Events

    • 21 Mar 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment because Funding was not obtained for this study and no participants were enrolled. .
    • 12 Oct 2016 Planned End Date changed from 1 Jul 2015 to 1 Jun 2020.
    • 12 Oct 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jun 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top